News & Events

Bioinformatics specialists explore the molecular mechanisms of ageing

Reducing the number of animal studies

Discovery of two novel classes of natural products with activity against RNA viruses

Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and…

Helmholtz Association funds interdisciplinary collaboration between two of its Research Fields

A research team from Saarbrücken develops a novel lung cell line for testing drugs

HIPS scientist receives funding to develop new antibiotics

Saarbrücken researchers use bacterial communication as a target for new drugs

Researchers from Saarbrücken and Freiburg develop promising active ingredient to combat multi-resistant bacteria.

Improved darobactin derivatives show activity against carbapenem-resistant hospital germs

New class of active agents to combat multi-resistant pathogens to be developed to market maturity in the coming years

Corramycin is a new compound with activity against Gram-negative pathogens

Over the next five years, 15 international doctoral students will be trained at Saarland University and HIPS.

New Department “Anti-infectives from Microbiota” at HIPS

Antimicrobial resistance (AMR) is becoming an increasing threat to human health. It is estimated that nearly 1.3 million deaths were caused by resistant bacteria in 2019. To…

In the concept phase, scientists develop implementation strategies for metabolites from fungi and a new class of active substances against malaria

We are very happy to welcome Alexey and his team at HIPS.

The floating Science Center will be anchored in Saarbrücken (near the Congresshalle in Bürgerpark) from August 5 to 8.

Researchers from Saarland receive millions in funding from Volkswagen Foundation

We warmly welcome Fabian and his team to HIPS.

Pharmacist Mariia Nesterkina built a fast-track career in Odessa. She has since had to flee the war, swapping her lab in Ukraine for a life in Saarland where she continues to…

Saarbrücken researchers optimize drug candidate against multi-resistant bacteria and parasites

New junior research group on single cell research at HIPS cooperates with Saarland University and Stanford University

HIPS scientists elucidate the biosynthesis of natural product Thioholgamide

Jerusalem, March 16 2022 - Terrapeutics Pharma (“Terrapeutics”) and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) are pleased to announce that they have…

We are delighted to welcome Julian Hegemann and his team at the HIPS.

HZI and HIPS start-up develops new class of antibiotics

Saarbrücken researchers develop drug candidates against hospital germs

Scientists at HIPS develop a screening tool for assessing bacterial bioavailability.

HIPS citizen science campaign boards the „MS Wissenschaft“

Claus-Michael Lehr wins the PHOENIX Pharmacy Science Award 2021

It often takes many years before a new active compound from basic research hits the market as a drug. In order to accelerate this process, the Helmholtz Institute for…

After five years as a junior professor at HIPS, Gregor Fuhrmann will take up a professorship in pharmaceutical biology at the Friedrich-Alexander-University Erlangen-Nuremberg…

Researchers from the Department of Microbial Natural Products improve the production of a new drug candidate.

International research alliance proposes strategy for the discovery and development of new active substances

The Alexander von Humboldt Foundation has selected Claus-Michael Lehr as a scout within the Henriette-Herz-Programme.This award allows him to select three young scientific…

Chantal Bader, postdoc in the Department of Microbial Natural Products, has been awarded a grant from the Hans-and-Ruth-Giessen-Foundation on 29 June 2021. As a talented young…

On the occasion of World Tuberculosis Day, Jennifer Herrmann, scientist in the department Microbial Natural Products, talks about the epidemiology of the disease and her…

Saarbrücken researchers develop novel strategy for treating hospital germs

Scientists from the Microbial Natural Products department reveal how myxobacteria produce antimicrobial compounds.

Scientists from the Department of Microbial Natural Products discover a new class of natural products in an unusual myxobacterial strain

HIPS Director receives most important research award in Germany

The Federal Budget Committee has assured the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) funding of 47 million euros for the further expansion of the…

Team of Prof Anna Hirsch receives 1.46 million Euros in funding

Gregor Fuhrmann and two other HZI scientists receive million-euro funding from the European Research Council

HIPS research group leader develops drug candidates and diagnostics for bacterial infections

HIPS takes part in the “Living Therapeutic Materials” project

HIPS researchers decipher a step in the biosynthesis of an antibiotically active natural product

Anna K. H. Hirsch coordinates EU-funded training of new generation of researchers

Novel vehicles increase the efficiency of antibiotics against chronic infections

Bill & Melinda Gates Foundation funds collaboration of the HZI/HIPS with Evotec to develop new drug approaches for treating tuberculosis and malaria

The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarland University and the Leibniz Institute for New Materials enter into an interdisciplinary…

The European Federation of Medical Chemistry awarded HIPS researcher Anna Hirsch the Runner-Up Prize as Young Medicinal Chemist in Academia 2019

HIPS researcher Gregor Fuhrmann has received the Young Investigators Award of the Horst Böhme Foundation of the German Pharmaceutical Society